ArticleACS omega2025
Engineering Three-Dimensional Cellular Organization by Regulating Bound Water-Mediated Cell-Substrate Interactions for Disease Modeling.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, organoid culture technologies have advanced rapidly as a method for constructing biomimetic models for studying tissue and organ physiology. However, reproducibly constructing complex organoid architectures using synthetic polymers, which are potential alternatives to conventional natural polymer gels derived from animal sources, remains challenging. Controlling cell-substrate interactions is crucial for regulating reproducible three-dimensional (3D) cell adhesion behaviors. In our previous study, we demonstrated that interactions between cells and substrates can be modulated by altering the hydrated water content of polymer coatings using poly-(2-methoxyethyl acrylate) (PMEA) derivatives. Based on these findings, we hypothesized that further increasing the hydrated water content of the coating polymer may induce a transition in the cell adhesion behavior from two-dimensional (2D) to 3D configurations. In this study, we focused on PMEA derivatives and synthesized a series of block copolymers with varying ethylene glycol (EG) side-chain lengths to control the bound water content on the substrate surface. Using atomic force microscopy-based single-cell force spectroscopy, we quantitatively demonstrated that increasing the bound water content of the surface polymer weakens cell-substrate interactions. This, in turn, enhances the relative contribution of cell-cell interactions and promotes 3D cell adhesion. Furthermore, we successfully used these polymer substrates to establish an in vitro model of metabolic dysfunction-associated steatohepatitis (MASH). This model successfully reproduced pathological features such as lipid accumulation and elevated expression of inflammatory cytokines interleukin-6 (IL-6) and interleukin-1β (IL-1β), thereby demonstrating their utility for drug screening applications. Our results present a novel strategy for guiding 3D cellular organization by modulating the hydrated water content of polymer coatings. These findings also suggested that PMEA derivatives are promising materials for 3D organoid engineering and disease modeling platforms.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.